Form 4 for NSPR InspireMD, Inc.
Accepted 2021-10-14 00:00:00 ET · period of report 2021-10-13 · accession 0001493152-21-025454 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-14 | 2021-10-13 | NSPR | Slosman Marvin | CEO, Pres, Dir | A - Grant | $0.00 | +146.6K | 243.5K | +151% | $0 |
| D | 2021-10-14 | 2021-10-13 | NSPR | Slosman Marvin | CEO, Pres, Dir | A - Grant | $0.00 | +48.9K | 48.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Restricted Stock Units | 2021-10-13 | A | A | 146,567 | $0.00 | 243,470 | D | — | — | (F1) These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service. |
| 2 | Derivative | Options to purchase common stock (right to buy) | 2021-10-13 | A | A | 48,855 | $0.00 | 48,855 | D | $4.12 · — to 2031-10-13 | 48,855 Common Stock | (F2) The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service. |